October 31, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Advaxis, Inc. (NASDAQ:ADXS) shares over potential misconduct by certain of its directors and officers in connection with the grant of certain stock options.

The investigation by a law firm concerns the grant of an aggregate of 1,567,595 stock options to the Compensation Committee and to the executive officers and directors of Advaxis, Inc. in 2015. In particular, the investigation focuses on whether there was an improper granting of spring-loaded stock options, as well as excessive and unfair compensation received by non-employee Board members.